Net income · Fiscal year 2025
| 1 | Johnson & JohnsonJNJ | $26.8B |
|---|---|---|
| 2 | Eli LillyLLY | $20.6B |
| 3 | MerckMRK | $18.3B |
| 4 | Novo Nordisk A SNVO | $15.5B |
| 5 | UnitedHealth GroupUNH | $12.1B |
| 6 | AstraZenecaAZN | $10.2B |
| 7 | Gilead SciencesGILD | $8.5B |
| 8 | PfizerPFE | $7.8B |
| 9 | AmgenAMGN | $7.7B |
| 10 | GSKGSK | $7.5B |